My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
12-20-21-SR
ArdenHills
>
Administration
>
City Council
>
City Council Packets
>
2020-2029
>
2021
>
12-20-21-SR
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
12/16/2021 1:10:50 PM
Creation date
12/16/2021 1:10:23 PM
Metadata
Fields
Template:
General
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
53
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
2 <br /> <br />suspicious orders. Johnson & Johnson will be prohibited from selling or promoting opioids <br />for ten years. <br /> <br />Minnesota Framework <br /> <br />Minnesota has been preparing for these settlements and the opportunity they present to deliver <br />substantial funding to needed abatement and remediation programs. In 2019, the Legislature <br />passed the Opiate Epidemic Response bill, creating a special opioid abatement account and the <br />Opioid Epidemic Response Advisory Council, which will oversee the spending of the state’s <br />share of settlement funds. <br /> <br />Additionally, a months-long partnership between the state and cities and counties has resulted in <br />a state-subdivision agreement (or “Minnesota Memorandum of Agreement”) that is designed to <br />maximize the settlement funds coming to the State of Minnesota and get them to where they are <br />needed most. The state-subdivision agreement details how the settlement money will be <br />allocated within the state and also sets out a structure for the distribution of opioid abatement <br />funds from pending bankruptcy plans with Purdue Pharma and Mallinckrodt. A copy of the <br />state-subdivision agreement can be found on the Attorney General’s website at <br />www.ag.state.mn.us/opioids. <br />Pursuant to the state-subdivision agreement—and assuming maximum payments— <br />approximately $296 million in funds paid to Minnesota and its cities and counties from the <br />Distributor and Johnson & Johnson settlements, as well as tens of millions of additional dollars <br />from the Purdue Pharma and Mallinckrodt bankruptcies, will be allocated as follows: <br /> Local Government Abatement Fund. Seventy-five percent (75%) of the abatement <br />funds will be paid directly to counties and certain municipalities that participate in the <br />settlement. Local government funds will be directly allocated to all participating <br />counties, and all participating municipalities that: (a) have populations of 30,000 or more, <br />(b) have filed lawsuits against the settling defendants, or (c) have public health <br />departments. To promote efficiency in the use of abatement funds and limit the <br />administratively burdensome disbursements of amounts that are too small to add a <br />meaningful abatement response, smaller, non-litigating municipalities will not receive a <br />direct allocation of settlement funds. The allocation percentages for each county and <br />municipality were determined by counsel for the subdivisions negotiating the national <br />settlement agreements and were calculated using data reflect the impact of the opioid <br />crisis on the subdivision. <br /> <br /> State Fund. Twenty-five percent (25) of the abatement funds will be paid directly to the <br />State. Pursuant to state law, these funds will go into the special opioid abatement account <br />to be overseen and distributed by the Opioid Epidemic Response Advisory Council. <br />Under current law, after certain appropriations are made, approximately 50% of the funds <br />paid into the opioid abatement account are distributed to county social service agencies to <br />provide child protection services to children and families who are affected by addiction.
The URL can be used to link to this page
Your browser does not support the video tag.